Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2015 by University of California, San Francisco.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genentech, Inc.
Sanofi
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00227617
First received: September 26, 2005
Last updated: April 7, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2016
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)